Slingshot members are tracking this event:

Regeneron Pharmaceuticals (REGN) expecting cardiovascular outcome Praluent, antibody, for lowering LDL cholesterol, to report data in early 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
REGN Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Praluent, Ldl Cholesterol